Track topics on Twitter Track topics that are important to you
TORONTO, Aug. 2, 2017 /PRNewswire/ - Symbility Solutions Inc. ("Symbility") (TSX.V: SY) a global software company focused on modernizing the insurance industry, has entered into a new partnership with DeepLearni.ng, a Toronto-based company providing artificial intelligence solutions for enterprise. The partnership will provide the knowledge and tools required to successfully introduce artificial intelligence into Symbility's technology stack.
By closely collaborating with Symbility's leadership, DeepLearni.ng has completed a comprehensive assessment of current opportunities in the company for artificial intelligence applications, based on impact and viability. Once deployed, these use cases would rapidly provide property insurance carriers and their vendor networks a new way to lower indemnity spend, provide better business insights, and most importantly, increase revenue.
"Symbility is very focused on a new suite of self service products for policyholders that leverage the data from the millions of property insurance claims we have processed over the years," stated James Swayze, CEO of Symbility Solutions. "We were impressed with the 40 percent efficiencies DeepLearni.ng generated for one of the world's largest banks while maintaining rigorous security and compliance requirements and wanted to incorporate their models into our applications. Having operated a cloud-based platform since our inception, we have every dataset on our servers and are excited to leverage artificial intelligence in the creation of a new product portfolio."
Both Symbility and DeepLearni.ng see massive potential for artificial intelligence to transform the InsurTech space. Some of the areas Symbility and DeepLearni.ng have already begun to explore include:
"The insurance industry is the perfect space for AI right now with all the resources required to get machine learning projects off the ground: lots of context-rich data and interesting use cases," says DeepLearni.ng's Co-Founder, Stephen Piron. "Getting to the bottom of Symbility's data assets and organizational context proved this for us. From the start of our partnership, we immediately saw Symbility's potential for artificial intelligence applications. Having such a volume of structured, formatted and indexed data allows us to accelerate our modeling with confidence over the accuracy of the results."
With a roadmap of use cases customized for the business established, the next step of Symbility and DeepLearni.ng's partnership is to begin the process of building and deploying the company's first artificial intelligence solution, which will be selected based on its viability for rapidly measurable results and long-term business impact.
Symbility (TSX.V: SY) believes in creating world-class experiences that simplify business and improve lives. With a history in modernizing insurance claims solutions for the property and health industries, Symbility has established itself as a partner that puts security, efficiency and customer experience first. Symbility PROPERTY™ brings smarter thinking to property insurance. Symbility HEALTH™ helps benefits professionals build their brands and businesses. Our strategic services team, Symbility INTERSECT™ empowers a variety of businesses with smarter mobile and IoT product development strategy, design thinking and engineering excellence. With our three segments pushing industries forward, Symbility proves that change for the better is entirely possible. symbilitysolutions.com
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
All trade names are the property of their respective owners.
SOURCE Symbility Solutions Inc.NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...